CDEK
← All trials

NCT06613685

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Oct 21, 2024
Primary completion
Jan 31, 2029
Completion date
Aug 31, 2030
First posted
Sep 26, 2024
Last posted
Oct 23, 2024
Enrollment
675
Arms / groups
6 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.